Patents by Inventor Marilyn Moore

Marilyn Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060147432
    Abstract: It has been found that dendritic cells can be prepared which cannot mature. These cells can provide signal 1 to T cells but cannot provide co-stimulatory signal 2. T cells which are stimulated by the permanently immature dendritic cells therefore anergise, so the dendritic cells are tolerogenic rather than immunogenic. The cells are generally CD40?ve, CD80?ve and CD86?ve, and remain so when stimulated by inflammatory mediators such as lipopolysaccharide. The cells can be prepared conveniently by the culturing adherent embryonic stem cells in the presence of GM-CSF.
    Type: Application
    Filed: February 24, 2006
    Publication date: July 6, 2006
    Applicant: Revivicor, Inc.
    Inventors: Marilyn Moore, Andrew Leishman, Donald Innes
  • Patent number: D624710
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: September 28, 2010
    Inventor: Marilyn Moore
  • Patent number: D883991
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: May 12, 2020
    Inventor: Marilyn Moore